Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
120Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $12.10M | $-3.61M | $-0.54 |
| 2024 | $3.45M | $-12.32M | $-2.76 |
| 2023 | $1.95M | $-11.86M | $-3.90 |
| 2022 | $171.2K | $-10.00M | $-3.78 |
| 2021 | $178.1K | $-9.95M | $-5.58 |
Social Signal Score
Earnings
Tue, Dec 15(in 4 months)
Consensus estimate $-0.20 per share
Typical surprise +22.2% (median, so one quarter with a near-zero estimate can't distort it)
- Thu, Aug 13$-0.28 vs $-0.21miss
- Tue, May 12$-0.25 vs $-0.23miss
- Tue, Feb 17$-0.18 vs $-0.24beat
- Wed, Dec 17$-0.05 vs $-0.04miss
- Thu, Aug 14$-0.03 vs $-0.05beat
- Tue, May 13$-0.07 vs $-0.09beat
Estimates and results for NMTC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
NMTChas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsseekingalpha.com·1d ago·Positive
NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript NeuroOne Medical Technologies Corporation (NMTC) Q3 2026 Earnings Call Transcript
View source ↗
